Literature DB >> 3036349

Vinca alkaloids in the treatment of non-small cell lung cancer.

J B Sørensen, K Osterlind, H H Hansen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3036349     DOI： 10.1016/0305-7372(87)90049-1

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  5 in total

1.  Etoposide in patients with previously untreated non-small-cell lung cancer: a phase I study.

Authors:  N Niederle; J Ostermann; W Achterrath; L Lenaz; C G Schmidt
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

2.  Clinical phase I and pharmacokinetic trial of vinorelbine administered as single intravenous bolus every 21 days in cancer patients.

Authors:  T Schilling; H H Fiebig; S Kerpel-Fronius; B Winterhalter; P Variol; P Tresca; B Heinrich; A R Hanauske
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

3.  Phase II study of carboplatin in untreated, inoperable non-small-cell lung cancer.

Authors:  U Gatzemeier; M Heckmayr; D K Hossfeld; R Zschaber; W Achterrath; L Lenaz
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 4.  The current and future place of vinorelbine in cancer therapy.

Authors:  E Cvitkovic; J Izzo
Journal:  Drugs       Date:  1992       Impact factor: 9.546

Review 5.  Vinorelbine. A review of its antitumour activity in lung cancer.

Authors:  J B Sørensen
Journal:  Drugs       Date:  1992       Impact factor: 9.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.